PTPRO and malignant colon neoplasm: Gene expression analyses of 688 primary colon tumour samples revealed that PTPRO mRNA expression is strongly down‐regulated in patients with colon cancer with a poor prognosis,39 and loss of PTPRO expression is associated with increased resistance to EGFR inhibition,25 suggesting that increased expression of PTPRO might be beneficial.